Glaxosmithkline reported GBP8.09B in Trade Debtors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Amgen AMGN:US USD 5.33B 1000K
AstraZeneca AZN:LN USD 10.06B 449M
Aurora Cannabis Inc ACB:CN CAD 45.94M 1.11M
Bristol Myers Squibb BMY:US USD 13.24B 700M
Canopy Growth Corp WEED:CN CAD 108.24M 11.61M
Catalent CTLT:US USD 1.41B 42M
Corcept Therapeutics CORT:US USD 29.41M 1.25M
Eli Lilly And LLY:US USD 8.32B 652.4M
Endo International Ordinary Shares ENDP:US USD 425.95M 75.15M
GlaxoSmithKline GSK:LN GBP 8.09B 1.22B
Glaxosmithkline GSK:US GBP 8.09B 1.22B
Horizon Pharma HZNP:US USD 646.39M 26.92M
Lannett LCI:US USD 74.43M 18.6M
Novartis NOVN:VX USD 8.68B 230M
Pacira Pharmaceuticals PCRX:US USD 93.47M 2.37M
Perrigo Ordinary Shares PRGO:US USD 739.5M 37.6M
Phibro Animal Health PAHC:US USD 142.73M 23.81M
Prestige Brands PBH:US USD 145.99M 541K
Supernus Pharmaceuticals SUPN:US USD 164.09M 6.02M
Takeda 4502:JP JPY 800.54B 6.44B
Teva Pharmaceutical TEVA:IT USD 3.73B 741M
Valeant Pharmaceuticals VRX:CN USD 1.74B 94M
Zoetis ZTS:US USD 1.19B 102M